Teladoc Health, Inc. (TDOC) is a renowned pioneer of telemedicine and virtual healthcare. Incorporated in Delaware in 2002, the company has a primary mission to transform how people access and experience healthcare, by making it more accessible and affordable for both individuals and healthcare systems. Its telehealth platform allows patients to receive 24/7 remote medical consultations from the comfort of their own homes, offices, or any other private setting of choice.
The company operates under a business model that connects patients with a network of physicians and behavioral health professionals through videoconferencing, phone calls, and online messaging. Teladoc's service stands out with its wide range of clinical services, including general medical, mental health, dermatology, diet and nutrition, sexual health, and tobacco cessation, amongst others. Undoubtedly, the company has revolutionized the healthcare system by providing a convenient and time-saving solution for non-emergency medical issues.
Essentially, the organization aims to reduce the barriers between patients and physicians and seeks to capitalize on the increased demand for telehealth spurred by the COVID-19 pandemic, rapidly digitalizing healthcare systems, and the sheer convenience virtual healthcare offers to the modern-day patient. It is committed to improve patient satisfaction, reduce healthcare cost, and drive positive clinical outcomes.
Furthermore, in 2020, the company made a significant expansion by acquiring Livongo, a leading Applied Health Signals company that empowers people with chronic conditions to live better and healthier lives. This move expanded Teladoc Health’s services, adding management for chronic conditions such as diabetes and hypertension, and strengthening its foothold in the digital health landscape.
Teladoc Health, Inc. (TDOC) is publicly listed on the New York Stock Exchange and has seen a notable increase in its stock value as telehealth services gained traction during the pandemic. While the company operates globally, its largest market is in the United States, where it serves millions of patients across all 50 states.
To sum up, Teladoc Health Inc. is committed to making healthcare simple, cost-effective, and versatile. As a pioneer in telemedicine services, it continues to push the boundaries of conventional healthcare delivery, thereby reshaping the future of healthcare.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Teladoc Health, Inc. (NYSE:TDOC) has announced that its Chief Legal Officer and Secretary, Adam C. Vandervoort, will resign effective November 1, 2026. Jonathan Dorfman, currently Senior Vice President, Securities and Corporate Law, will succeed him. Vandervoort will provide uncompensated advisory and transition support until November 1, 2027.
Teladoc (TDOC) shares closed down 3.46% in the latest trading session, underperforming the S&P 500's daily loss. Investors are anticipating the company's upcoming earnings report, with EPS projected to decrease by 9.52% and revenue by 6.53% compared to the same quarter last year. Despite a recent 1.78% lower revision in the Zacks Consensus EPS estimate, Teladoc currently holds a Zacks Rank of #3 (Hold).
Teladoc Health recently reported weak Q2 results, missing analyst expectations on revenue and EBITDA, and issued lower guidance for the next quarter. The company experienced a 4% year-on-year revenue decline and a 9.2% average drop in customer spending, which puts pressure on its core business model and raises concerns about its investment narrative. Despite a projected fair value offering a 27% upside, ongoing unprofitability and pricing pressures highlight the need for Teladoc to stabilize revenue per user.
Teladoc Health has appointed Michael Grasher as its new Chief Financial Officer, effective immediately. Grasher brings over three decades of financial experience across insurance and financial services, including more than 12 years in CFO roles for public and private companies. His appointment is expected to strengthen Teladoc Health's financial leadership as it focuses on strategic execution and long-term growth.